RecruitingNCT06470607
The Lymphocytic Infiltrate of Lung Tumors.
Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors
Sponsor
Scientific Institute San Raffaele
Enrollment
70 participants
Start Date
Jan 20, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The study is configured as a monocentric observational transversal biological study. The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity, in particular non-small cell lung cancer (NSCLC). The study involves the collection of clinical data and biological material (blood and tumor tissue) from 70 subjects diagnosed with thoracic tumors.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Ability to provide informed consent;
- Men and women over the age of 18;
- Patients candidates for surgical treatment diagnosed with thoracic tumors
Exclusion Criteria3
- Previous chemotherapy for any cancer within the last 6 months;
- Pregnant and/or breastfeeding women;
- Immunosuppressive state (states of immunosuppression or ongoing immunosuppressive/immunomodulatory treatments)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06470607
Related Trials
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Virtual Agent Feasibility in Oncology Patients (NTT Data)
NCT066820131 location
Empathic Communication Skills (ECS) Training
NCT0545684112 locations
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
NCT0661828763 locations
Study of Novel Treatment Combinations in Patients With Lung Cancer
NCT05633667100 locations